Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype (Q36610844)

15 August 2017

Conversion to sirolimus in kidney transplant recipients with squamous cell cancer and changes in immune phenotype (English)

1 reference

15 August 2017

1 reference

Robert P Carroll

1 reference

15 August 2017

Joanna Hester

series ordinal

1 reference

15 August 2017

Kathryn J Wood

series ordinal

1 reference

15 August 2017

Paul N Harden

series ordinal

1 reference

15 August 2017

language of work or name

English

0 references

publication date

7 December 2012

1 reference

Nephrology Dialysis Transplantation

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

462-465

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

15 August 2017

start time

6 October 2016

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Acute rejection in low-toxicity regimens: clinical impact and risk factors in the Symphony study

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Reduced exposure to calcineurin inhibitors in renal transplantation

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Reduced numbers of blood natural regulatory T cells in stable liver transplant recipients with high levels of calcineurin inhibitors.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Decreased skin cancer after cessation of therapy with transplant-associated immunosuppressants.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572772

Long-term kinetic of T-lymphocyte subsets in kidney-transplant recipients: influence of anti-T-cell antibodies and association with posttransplant malignancies

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23223314

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23223314

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/NDT/GFS474

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23223314

1 reference